FDA Drug Application (202845) for DIFLUNISAL by HERITAGE PHARMA

Back to FDA Applications sponsored by HERITAGE PHARMA

Application Number202845
Product Number001
FormTABLET;ORAL
Dosage500MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameDIFLUNISAL
Active IngredientDIFLUNISAL

Active IngredientCount
List of drugs with Active Ingredient DIFLUNISAL2


Back to FDA Applications sponsored by HERITAGE PHARMA